Dr. Yash is a leading head and neck surgical oncologist at HCG Cancer Centre, Mumbai.
Dr. Yash is an expert in the management of midfacial malignancies and tumours especially those arising from maxilla facial structures.
Dr. Yash is also experienced in the surgical management of advanced oral, oropharyngeal & salivary gland malignancies.
He also specialises in minimal access resections for advanced oral cancers, complex primaries especially the tongue, cheek and lip cancer.
He gives prime importance to rehabilitation based reconstruction for early and advanced head and neck cancers and also performs head and neck reconstructive surgeries with expertise in local and pedicled flaps with a focus on achieving better aesthetic and cosmetic outcomes.
Dr. Yash has handled more than 5000 cancer cases so far.
Training and Certifications
Dr. Yash has completed his fellowship training in head and neck cancer surgery from Tata Memorial Hospital, Mumbai.
He has undergone training in implant-based reconstruction of oral and craniofacial defects post-surgery from KLE University, Belgaum.
Dr. Yash regularly participates in workshops, conferences that are held at national and international levels.
He has been invited as a speaker, faculty at various CMEs and conferences at national and state levels.
Outcome, patterns of failure and toxicity profile following adjuvant intensity-modulated radiotherapy for oral cavity squamous cell carcinomas. C paper ESMO 2020
Depth Of Invasion, size and number of metastatic nodes predicts extracapsular spread in early oral cancers with occult metastases. Oral onco. 2018 Jun; 81:95-99.
The Role of Neutrophil- to Lymphocyte Ratio and Platelet – to-Lymphocyte Ratio as Prognostic Markers in the Oral cavity. Indian Journal of Paediatric & Medical oncology 2018.
Outcome of patients following neoadjuvant chemotherapy for unresectable cervical nodes in head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol. 2018 Dec.
Oral Cancer and Reconstruction: A Case Report. Saudi Journal of Medicine 2019 Sept.
Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre. 2020 March
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.